NBY logo

NovaBay Pharmaceuticals (NBY) Operating Expenses

Annual Operating Expenses

$12.90 M
-$2.56 M-16.58%

December 1, 2023

Summary

Performance

1-Year Change

-16.58%

3-Year Change

+4.1%

5-Year Change

-31.67%

15-Year Change

-43.32%

NBY Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

13.59%
NBY annual total operating expenses is higher than 13.59% of companies in Healthcare sector

High & Low

All-time High

$24.26 M
NBY annual total operating expenses is currently -46.83% below its historical high of $24.26 million

3-Year Low

$12.90 M
NBY annual total operating expenses is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
NBY previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
NBY next annual earnings announcement has not yet been scheduled

OtherNBYexpensesmetrics:

Annual Total Expenses

$19.73 M
NBY annual total expenses is $19.73 million

Annual Interest Expense

-
NBY annual interest expense value is unknown

Annual Income Tax

-
NBY annual income tax value is unknown

Annual Cost Of Goods Sold

$6.83 M
NBY annual cost of goods sold is $6.83 million

Quarterly Operating Expenses

$2.65 M
+$9000.00+0.34%

September 1, 2024

Summary

Performance

3-Month Change

+0.34%

1-Year Change

+12.46%

3-Year Change

-4.87%

5-Year Change

-4.87%

NBY Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

12.12%
NBY quarterly total operating expenses is higher than 12.12% of companies in Healthcare sector

High & Low

All-time High

$7.31 M
NBY quarterly total operating expenses is currently -63.71% below its historical high of $7.31 million

3-Year Low

$2.36 M
NBY quarterly total operating expenses is currently +12.46% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
NBY previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
NBY next earnings announcement has not yet been scheduled

OtherNBYexpensesmetrics:

Quarterly Total Expenses

$3.50 M
NBY quarterly total expenses is $3.50 million

Quarterly Interest Expense

$138.00 K
NBY quarterly interest expense is $138.00 thousand

Quarterly Income Tax

-
NBY quarterly income tax value is unknown

Quarterly Cost Of Goods Sold

$848.00 K
NBY quarterly cost of goods sold is $848.00 thousand

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

Annual Operating Expenses

$12.90 M
NBY annual total operating expenses is $12.90 million

Annual SGA

$12.83 M
NBY annual SGA is $12.83 million

Annual D&A

$203.00 K
NBY annual depreciation & amortization is $203.00 thousand

NBY Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-16.6%+12.5%
3 y3 years+4.1%-4.9%
5 y5 years-31.7%-4.9%

NBY Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-16.6%at low-45.5%+12.5%
5 y5-year-16.6%+4.1%-45.5%+12.5%
alltimeall time-46.8%+1253.4%-63.7%+12.5%

NovaBay Pharmaceuticals Operating Expenses History

DateAnnualQuarterly
Sep 2024
-
$2.65 M(+0.3%)
Jun 2024
-
$2.65 M(-21.4%)
Mar 2024
-
$3.37 M(-29.9%)
Dec 2023
$12.90 M(-16.6%)
$4.80 M(+103.5%)
Sep 2023
-
$2.36 M(-15.4%)
Jun 2023
-
$2.79 M(-5.3%)
Mar 2023
-
$2.94 M(-33.7%)
Dec 2022
$15.46 M(+0.5%)
$4.44 M(+56.9%)
Sep 2022
-
$2.83 M(-29.0%)
Jun 2022
-
$3.99 M(-4.9%)
Mar 2022
-
$4.20 M(-13.9%)
Dec 2021
$15.38 M(+24.1%)
$4.87 M(+26.8%)
Sep 2021
-
$3.84 M(+13.7%)
Jun 2021
-
$3.38 M(+17.6%)
Mar 2021
-
$2.87 M(+1.4%)
Dec 2020
$12.39 M(-13.1%)
$2.83 M(-23.3%)
Sep 2020
-
$3.70 M(+22.6%)
Jun 2020
-
$3.02 M(+5.9%)
Mar 2020
-
$2.85 M(-15.0%)
Dec 2019
$14.26 M(-24.4%)
$3.35 M(+14.5%)
Sep 2019
-
$2.93 M(+5.8%)
Jun 2019
-
$2.77 M(-47.0%)
Mar 2019
-
$5.22 M(+8.9%)
Dec 2018
$18.88 M(-17.1%)
$4.79 M(+3.8%)
Sep 2018
-
$4.62 M(+5.0%)
Jun 2018
-
$4.40 M(-13.2%)
Mar 2018
-
$5.06 M(+2.4%)
Dec 2017
$22.76 M(+11.5%)
$4.95 M(-13.8%)
Sep 2017
-
$5.74 M(+10.8%)
Jun 2017
-
$5.18 M(-24.8%)
Mar 2017
-
$6.89 M(+30.0%)
Dec 2016
$20.41 M(-15.8%)
$5.30 M(+7.4%)
Sep 2016
-
$4.93 M(+11.5%)
Jun 2016
-
$4.42 M(-23.2%)
Mar 2016
-
$5.76 M(-21.2%)
Dec 2015
$24.26 M
$7.31 M(+16.5%)
Sep 2015
-
$6.28 M(+11.8%)
DateAnnualQuarterly
Jun 2015
-
$5.61 M(+11.1%)
Mar 2015
-
$5.05 M(-1.4%)
Dec 2014
$17.47 M(-7.1%)
$5.12 M(+21.3%)
Sep 2014
-
$4.22 M(+8.5%)
Jun 2014
-
$3.89 M(-8.1%)
Mar 2014
-
$4.24 M(-20.0%)
Dec 2013
$18.80 M(+23.3%)
$5.30 M(+31.2%)
Sep 2013
-
$4.04 M(-18.9%)
Jun 2013
-
$4.98 M(+11.1%)
Mar 2013
-
$4.49 M(+13.6%)
Dec 2012
$15.25 M(-0.6%)
$3.95 M(+5.3%)
Sep 2012
-
$3.75 M(+0.1%)
Jun 2012
-
$3.75 M(-1.6%)
Mar 2012
-
$3.81 M(+2.9%)
Dec 2011
$15.34 M(+7.5%)
$3.70 M(+18.5%)
Sep 2011
-
$3.12 M(-23.7%)
Jun 2011
-
$4.09 M(-7.8%)
Mar 2011
-
$4.43 M(+43.2%)
Dec 2010
$14.27 M(+10.2%)
$3.10 M(-17.0%)
Sep 2010
-
$3.73 M(-0.2%)
Jun 2010
-
$3.74 M(+1.0%)
Mar 2010
-
$3.70 M(-8.8%)
Dec 2009
$12.94 M(-15.0%)
$4.06 M(+22.5%)
Sep 2009
-
$3.31 M(+25.7%)
Jun 2009
-
$2.63 M(-10.4%)
Mar 2009
-
$2.94 M(-22.5%)
Dec 2008
$15.23 M(+29.2%)
$3.79 M(+20.2%)
Sep 2008
-
$3.16 M(-20.0%)
Jun 2008
-
$3.95 M(-8.9%)
Mar 2008
-
$4.33 M(+40.4%)
Dec 2007
$11.79 M(+67.0%)
$3.08 M(+0.4%)
Sep 2007
-
$3.07 M(-2.0%)
Jun 2007
-
$3.13 M(+25.5%)
Mar 2007
-
$2.50 M
Dec 2006
$7.06 M(+97.8%)
-
Dec 2005
$3.57 M(+274.5%)
-
Dec 2003
$953.00 K
-

FAQ

  • What is NovaBay Pharmaceuticals annual total operating expenses?
  • What is the all time high annual operating expenses for NovaBay Pharmaceuticals?
  • What is NovaBay Pharmaceuticals annual operating expenses year-on-year change?
  • What is NovaBay Pharmaceuticals quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for NovaBay Pharmaceuticals?
  • What is NovaBay Pharmaceuticals quarterly operating expenses year-on-year change?

What is NovaBay Pharmaceuticals annual total operating expenses?

The current annual operating expenses of NBY is $12.90 M

What is the all time high annual operating expenses for NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals all-time high annual total operating expenses is $24.26 M

What is NovaBay Pharmaceuticals annual operating expenses year-on-year change?

Over the past year, NBY annual total operating expenses has changed by -$2.56 M (-16.58%)

What is NovaBay Pharmaceuticals quarterly total operating expenses?

The current quarterly operating expenses of NBY is $2.65 M

What is the all time high quarterly operating expenses for NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals all-time high quarterly total operating expenses is $7.31 M

What is NovaBay Pharmaceuticals quarterly operating expenses year-on-year change?

Over the past year, NBY quarterly total operating expenses has changed by +$294.00 K (+12.46%)